🔆 BeaconThis page is also available in English

Essais cliniques au Canada : trouble bipolaire

21 essais en recrutement dans le registre officiel · mis à jour en juillet 2026 · gratuit · sans compte · sans pistage · English & français

Chercher près de chez vous →

Cannabidiol for Bipolar Depression (CBD-BD)

Recruiting nowPhase 36 sites

Bipolar disorder (BD) is a lifelong condition characterized by recurrent episodes of depression and (hypo)mania. Periods of chronic and recurring depressive episodes are more common and can be severely disabling. Effective treatments exist;…

Transcranial Photobiomodulation for Bipolar Depression

Opening soon1 site

This study the effectiveness and safety of light therapy device targeted at the brain using a wearable device, the Vielight RX Gamma as a treatment for bipolar depression. Up to forty patients with bipolar disorder will be enrolled into the…

Theta-Burst Stimulation for Bipolar Depression

Recruiting now2 sites

The purpose of this trial is to determine if intermittent theta-burst stimulation (iTBS) can reduce the symptoms of depression in treatment-resistant bipolar disorder. To do this, some of the participants in this study will receive treatmen…

Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar Disorder

Recruiting now1 site

Dialectical behavior therapy (DBT) will be conducted over 1 year in youth with and/or at familial risk for bipolar disorder (BD). DBT will be divided into two modalities: 1) DBT skills training; and 2) DBT individual therapy sessions. Skill…

Three-level Model of DBT-informed Care for Youth With and/or at Familial Risk for Bipolar Disorder (DB3)

Recruiting now1 site

This study seeks to bridge the knowledge-to-action gap regarding psychosocial treatment "dosing" for youth with and/or at familial risk for bipolar disorder (BD). In psychiatry, pragmatic collaborative decisions between patient and care pro…

Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster Sessions for Youth With and/or at Familial Risk for Bipolar Disorder

Recruiting now1 site

The study intervention is DBT adapted for youth with and/or at familial risk for bipolar disorder. Participants will have completed one full year of DBT in a previous study. This study is examining use of booster sessions. It is delivered i…

SYNCED - SYNChronized Eating in Bipolar Depression Study

Recruiting now1 site

Bipolar disorders (BD) are a group of complex disorders that impact mood, behaviour and cognition and are known to cause significant suffering and impairment. Circadian rhythm (your internal day/night "clock") disruption, which can involve …

Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

Opening soonPhase 33 sites

This study is a 12-week (in addition to up to 30 days of screening) randomized, double-blind, placebo-controlled, parallel-group trial. The primary objective of this study is to assess the effectiveness, safety, and tolerability of single-d…

Brexpiprazole Treatment for Bipolar I Depression

Recruiting nowPhase 33 sites

Bipolar disorder (BD) is a frequent and lifelong recurrent mood disorder with treatment-resistant depressive episodes. Importantly, depressive symptoms and cognitive decline are major determinants of functionality and quality of life in thi…

Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder

Recruiting now1 site

People with bipolar disorder (BD) are at high risk of relapse following hospital discharge, partly due to a lack of BD-specific expertise and resources within community services required for comprehensive treatment. Although clinical guidel…

Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression

Recruiting nowPhase 11 site

This study is an open-label, single-arm, proof-of-concept study, wherein treatment resistant bipolar depression (TRBD) participants will receive one 25 mg dose of oral psilocybin accompanied by preparatory, monitoring, and integration psych…

An Innovative Master Platform for Clinical Trials in Mood Disorders

Recruiting now9 sites

Mood disorders such as depression and bipolar disorder affect over 350 million people around the world. While several effective treatments exist, it is often difficult to match the right treatment to an individual person. Repeated efforts t…

DIALOG: Understanding Disorganisation: A Language-focused Global Initiative in Psychosis

Opening soon1 site

Disorganized speech, language and communication, also called 'formal thought disorder,' is a key part of severe mental illnesses like psychosis and mood disorders. When someone's communication is disorganized, it makes social interactions d…

Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression

Recruiting nowPhase 32 sites

The purpose of this trial is to conduct an adequately powered clinical trial of once daily LFR for individuals diagnosed with treatment-resistant BD-DE who have not responded to iTBS or sham treatment applied to the left DLPFC. This work wi…

Skills for Wellness

Recruiting now2 sites

Severe mental illness such as schizophrenia and mood disorders typically develops at a young age and can cause life-long disability. Currently available treatments cannot cure severe mental illness. This makes it important to find ways to p…

Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression

Recruiting now1 site

The goal of this clinical trial is to evaluate the safety and initial effectiveness of MR-guided focused ultrasound (MRgFUS) bilateral capsulotomy in patients with treatment-resistant bipolar depression (TRBD).

'Thriving With Bipolar Disorder': Co-design and Evaluation of a Peer-Led Education Program Focused on Quality of Life

Opening soon1 site

Self-management strategies can be used by individuals with bipolar disorder (BD) to cope with symptoms and improve quality of life (QoL). Peer-facilitated education programs have the potential to diversify delivery of self-management inform…

The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry

Recruiting now1 site

While effective interventions for depression exist, their success rates are unsatisfactory and their provision is haphazard. The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Depression Hub will improve the deliver…

Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use

Recruiting now1 site

Severe mental illness (SMI) refers to the most burdensome psychiatric conditions. The need to pre-empt the onset of SMI is pressing because once SMI develops, quality of life is poor and available treatments have limited efficacy. Most risk…

Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories

Recruiting now1 site

Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health (BLOOM) is a project that aims to overcome age and diagnostic boundaries to generate person-specific longitudinal profiles of mental health in you…

Pharmacogenomics-Supported Psychotropic Prescribing Trial

Recruiting now2 sites

Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.

Questions fréquentes

Comment trouver un essai clinique (trouble bipolaire) près de chez moi au Canada ?

Utilisez la recherche gratuite de Beacon : entrez « trouble bipolaire », votre âge et votre lieu, et vous verrez les essais en recrutement triés par distance, chacun expliqué en langage clair — y compris les sites juste de l'autre côté de la frontière américaine. Beacon interroge le registre officiel complet et n'exige jamais de compte.

Participer à un essai clinique coûte-t-il de l'argent ?

Le traitement à l'étude et les examens liés à l'étude sont habituellement fournis sans frais, et certains essais aident avec les déplacements. Au Canada, votre régime provincial d'assurance maladie continue de couvrir vos soins courants — confirmez toujours les détails avec l'équipe de l'étude.

Puis-je quitter un essai clinique après y avoir adhéré ?

Oui. La participation est toujours volontaire et vous pouvez quitter un essai à tout moment, pour n'importe quelle raison, sans perdre vos soins médicaux habituels.

Suis-je admissible à ces essais ?

Chaque essai a ses propres critères d'admissibilité. Beacon traduit les critères de chaque essai en une liste en langage clair que vous pouvez passer en revue et apporter à votre médecin — seule l'équipe de l'étude peut confirmer votre admissibilité.

Page mise à jour en juillet 2026.

Beacon est un outil d'information, pas un avis médical. La décision de participer à un essai vous appartient, à vous, à votre médecin et à l'équipe de l'étude. Les détails proviennent du registre officiel ClinicalTrials.gov et peuvent changer — confirmez toujours auprès de l'équipe de l'étude. Beacon ne collecte aucune donnée sur vous : cette page n'a ni témoins, ni comptes, ni pistage.